World Hemophilia Day is observed on April 17. It raises awareness about bleeding disorders. Hemophilia is a genetic condition ...

Hemophilia is a genetic bleeding disorder where the blood doesn't clot properly due to a deficiency of clotting factors.

over 6000 assets (including all Forex pairs, Cryptocurrencies, Commodities, Indices and US stocks) unique interbank rates extensive historic data the option to save your configuration Here below ...

The U.S. Food and Drug Administration (FDA) has approved Qfitlia, a groundbreaking hemophilia treatment by French pharmaceutical giant Sanofi (NASDAQ: SNY).Designed for patients aged 12 and older ...

But the company could not build a sustainable business and many of the 15 million people who gave their genetic information to the platform are worried about where their personal data could end up.

It turns out the unique color is caused by a recessive genetic mutation, rather than the expression of a gene known to turn cats white. The pretty black, white, and grey shade—named for a ...

Qfitlia is indicated in the U.S. for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12 years of age and older with hemophilia A or B ...

The assay now can measure antithrombin (AT) activity levels for people treated with Qfitlia Qfitila will support people living with hemophilia ... broadly to detect genetic or acquired AT ...

Over the last three years, the FDA has approved six new hemophilia drugs, including three gene therapies. Into this crowded treatment landscape comes another new medicine as the FDA has signed off ...